USE OF CC-CHEMOKINES CCL5 / RANTES MUTANTS FOR THE TREATMENT OF LIVER DISEASES

摘要

CC-Chemokine mutants having reduced Glycosaminoglycans (GAG)-binding properties are effective against liver fibrotic inflammatory and/or autoimmune diseases. Particularly preferred are the mutants of CCL5/RANTES having reduced GAG-binding properties.